PHARMACOKINETICS OF CIPROFLOXACIN

被引：56

作者：

BERGAN, T

DALHOFF, A

ROHWEDDER, R

机构：

[1] AKER HOSP,OSLO 5,NORWAY

[2] BAYER AG,CTR PHARMA RES,D-5600 WUPPERTAL 1,FED REP GER

来源：

关键词：

D O I：

10.1007/BF01650500

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：S3 / S13

页数：11

共 96 条

[1] AROSIO E, 1985, RECENT ADV CHEMOTHER, P1789
[2] AUBERT J, 1986, INT S NEW QUINOLONES
[3] DOSE-DEPENDENT PHARMACOKINETIC STUDY OF PEFLOXACIN, A NEW ANTIBACTERIAL AGENT, IN HUMANS
BARRE, J
HOUIN, G
TILLEMENT, JP
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (10) : 1379 - 1382
[4] BEERMANN D, 1984, J CLIN PHARMACOL, V24, P403
[5] BEERMANN D, 1987, AM J MED, V82, P360
[6] BEERMANN D, 1986, 1ST INT CIPR WORKSH, P141
[7] PHARMACOKINETICS OF CIPROFLOXACIN AFTER INTRAVENOUS AND INCREASING ORAL DOSES
BERGAN, T
THORSTEINSSON, SB
KOLSTAD, IM
JOHNSEN, S
[J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1986, 5 (02) : 187 - 192
[8] PHARMACOKINETICS OF CIPROFLOXACIN AND EFFECT OF REPEATED DOSAGE ON SALIVARY AND FECAL MICROFLORA
BERGAN, T
DELIN, C
JOHANSEN, S
KOLSTAD, IM
NORD, CE
THORSTEINSSON, SB
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (02) : 298 - 302
[9] BERGAN T, 1987, FORTSCHR ANTIMIKROB, V6, P447
[10] BERGAN T, 1986, 1ST P INT CIPR WORKS, P111